Joel Greenblatt's MD Position Overview
Joel Greenblatt (via Gotham Asset Management, LLC) currently holds 123,393 shares of Pediatrix Medical Group, Inc. (MD) worth $2.64 M, representing 0.01% of the portfolio. First purchased in 2013-Q2, this long-term strategic position has been held for 49 quarters.
Based on 13F filings since 2013, Joel Greenblatt has maintained a long-term strategic position in MD, representing a significant commitment to this investment thesis. Largest addition occurred in Q3 2014, adding 701,943 shares. Largest reduction occurred in Q4 2014, reducing 820,927 shares.
Analysis based on 13F filings available since 2013 Q2
Joel Greenblatt's Pediatrix Medical Group (MD) Holding Value Over Time
Track share changes against reported price movement
Quarterly Pediatrix Medical Group (MD) Trades by Joel Greenblatt
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2026 | +10,540 | Add 9.34% | 123,393 | $21.39 |
| Q4 2025 | -3,240 | Reduce 2.79% | 112,853 | $21.39 |
| Q3 2025 | +724 | Add 0.63% | 116,093 | $16.75 |
| Q2 2025 | +40,822 | Add 54.76% | 115,369 | $14.35 |
| Q1 2025 | +19,905 | Add 36.43% | 74,547 | $14.49 |
| Q4 2024 | +15,044 | Add 37.99% | 54,642 | $13.12 |
| Q3 2024 | +39,598 | New Buy | 39,598 | $11.59 |
| Q2 2024 | -36,957 | Sold Out | 0 | $0.00 |
| Q1 2024 | +12,200 | Add 49.28% | 36,957 | $10.03 |
| Q4 2023 | -8,539 | Reduce 25.65% | 24,757 | $9.30 |
| Q3 2023 | +11,271 | Add 51.17% | 33,296 | $12.71 |
| Q2 2023 | -3,055 | Reduce 12.18% | 22,025 | $14.21 |
| Q1 2023 | +25,080 | New Buy | 25,080 | $14.91 |
| Q2 2022 | -33,504 | Sold Out | 0 | $0.00 |
| Q1 2022 | +299 | Add 0.90% | 33,504 | $23.49 |
| Q4 2021 | -8,986 | Reduce 21.30% | 33,205 | $27.22 |
| Q3 2021 | -4,022 | Reduce 8.70% | 42,191 | $28.42 |
| Q2 2021 | +29,483 | Add 176.23% | 46,213 | $30.14 |
| Q1 2021 | -12,155 | Reduce 42.08% | 16,730 | $25.46 |
| Q4 2020 | -15,511 | Reduce 34.94% | 28,885 | $24.55 |
| Q3 2020 | +5,892 | Add 15.30% | 44,396 | $16.29 |
| Q2 2020 | -107,310 | Reduce 73.59% | 38,504 | $17.09 |
| Q1 2020 | +10,224 | Add 7.54% | 145,814 | $11.64 |
| Q4 2019 | +86,880 | Add 178.36% | 135,590 | $27.79 |
| Q3 2019 | -75,952 | Reduce 60.93% | 48,710 | $22.62 |
| Q2 2019 | -95,732 | Reduce 43.44% | 124,662 | $25.23 |
| Q1 2019 | +26,521 | Add 13.68% | 220,394 | $27.17 |
| Q4 2018 | +193,873 | New Buy | 193,873 | $33.00 |
| Q3 2018 | -42,306 | Sold Out | 0 | $0.00 |
| Q2 2018 | -141,589 | Reduce 76.99% | 42,306 | $43.28 |
| Q1 2018 | +125,865 | Add 216.90% | 183,895 | $55.63 |
| Q4 2017 | -1,921 | Reduce 3.20% | 58,030 | $53.44 |
| Q3 2017 | +59,951 | New Buy | 59,951 | $43.12 |
| Q2 2017 | -111,724 | Sold Out | 0 | $0.00 |
| Q1 2017 | +107,890 | Add 2814.03% | 111,724 | $69.38 |
| Q4 2016 | +3,834 | New Buy | 3,834 | $66.77 |
| Q2 2016 | -351,118 | Sold Out | 0 | $0.00 |
| Q1 2016 | +85,374 | Add 32.13% | 351,118 | $64.62 |
| Q4 2015 | +240,668 | Add 959.75% | 265,744 | $71.66 |
| Q3 2015 | -52,619 | Reduce 67.73% | 25,076 | $76.81 |
| Q2 2015 | -9,509 | Reduce 10.90% | 77,695 | $74.11 |
| Q1 2015 | -1,096 | Reduce 1.24% | 87,204 | $72.51 |
| Q4 2014 | -820,927 | Reduce 90.29% | 88,300 | $66.12 |
| Q3 2014 | +701,943 | Add 338.64% | 909,227 | $54.82 |
| Q2 2014 | +50,000 | Add 31.79% | 207,284 | $58.15 |
| Q1 2014 | -187,190 | Reduce 54.34% | 157,284 | $61.98 |
| Q4 2013 | +180,520 | Add 110.10% | 344,474 | $53.38 |
| Q3 2013 | +11,610 | Add 7.62% | 163,954 | $50.20 |
| Q2 2013 | +152,344 | Add 0.00% | 152,344 | $45.79 |
Joel Greenblatt's Pediatrix Medical Group Investment FAQs
Joel Greenblatt first purchased Pediatrix Medical Group, Inc. (MD) in Q2 2013, acquiring 152,344 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Joel Greenblatt has held Pediatrix Medical Group, Inc. (MD) for 49 quarters since Q2 2013.
Joel Greenblatt's largest addition to Pediatrix Medical Group, Inc. (MD) was in Q3 2014, adding 909,227 shares worth $49.84 M.
According to the latest 13F filing for Q1 2026, Joel Greenblatt's firm, Gotham Asset Management, LLC, owns 123,393 shares of Pediatrix Medical Group, Inc. (MD), valued at approximately $2.64 M.
As of the Q1 2026 filing, Pediatrix Medical Group, Inc. (MD) represents approximately 0.01% of Joel Greenblatt's publicly disclosed stock portfolio, making it one of their key holdings.
Joel Greenblatt's peak holding in Pediatrix Medical Group, Inc. (MD) was 909,227 shares, as reported at the end of Q3 2014.